Verition Fund Management LLC Nrx Pharmaceuticals, Inc. Transaction History
Verition Fund Management LLC
- $16.5 Billion
- Q2 2024
A detailed history of Verition Fund Management LLC transactions in Nrx Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 10,000 shares of NRXP stock, worth $16,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$16,400% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NRXP
# of Institutions
2Shares Held
17.4KCall Options Held
0Put Options Held
0About NRX Pharmaceuticals, Inc.
- Ticker NRXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,641,296
- Market Cap $111M
- Description
- NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...